Industry – Page 10 – Swanson Reed | Specialist R&D Tax Advisors

Revolutionizing Mortgage Technology: Aidium’s $19 Million Series A Funding

Aidium, Inc., a leading player in the mortgage technology sector, has announced the completion of its $19 million Series A funding round led by PeakSpan Capital.

In a mortgage market marked by challenges, this substantial investment not only underscores PeakSpan’s confidence in Aidium’s mission but also highlights the intrinsic value of its solutions.

In today’s evolving mortgage landscape, loan officers face a critical choice: embrace advanced technological solutions or risk falling behind. PeakSpan Capital’s PropTech team recognizes the pivotal role of next-generation CRM platforms integrated with sales and marketing automation. Aidium stands out as a frontrunner in providing comprehensive solutions for mortgage lenders.

Under the visionary leadership of CEO Spencer Dusebout, Aidium is committed to equipping mortgage lenders with a unified platform that streamlines borrower engagement from start to finish. The platform boasts features such as business intelligence/reporting, data warehousing, pipeline management, and enterprise-grade permissioning, addressing critical market needs with an intuitive interface and robust integration capabilities.

Spencer Dusebout, CEO of Aidium, expressed his excitement about the partnership with PeakSpan Capital, emphasizing the validation of their commitment to innovation and vision for transforming the mortgage industry.

The Series A funding infusion will enable Aidium to further enhance its platform, expand its customer base, and solidify its leadership position in the mortgage technology landscape. With a focus on simplifying processes, driving ROI for clients, and providing unmatched customer support, Aidium is poised for rapid growth and sustained success.

Kyle Reitinger, Vice President of PeakSpan, echoed the sentiment, emphasizing Aidium’s ability to scale revenue and roll out powerful new data products despite the challenges in the mortgage environment. The investment signifies a tremendous opportunity for further innovation in the category, and PeakSpan is committed to supporting Aidium in the years ahead.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

KODE Labs Secures $30M Series B Funding

Detroit-based autonomous smart building startup KODE Labs announced the successful closure of a robust $30 million Series B funding round. Spearheaded by Maverix Private Equity and joined by esteemed partners TELUS Ventures and existing investor I Squared Capital, this investment marks a pivotal moment for KODE Labs, propelling its mission to help buildings worldwide achieve net-zero emissions.

Founded in October 2017 by brothers Edi and Etrit Demaj, alongside Gentrit Gojani, KODE Labs has swiftly emerged as a frontrunner in the realm of smart building technology. Recognizing buildings as a major contributor to global carbon emissions, the company is dedicated to enhancing the intelligence, health, and efficiency of buildings, enriching the experiences of occupants and visitors alike.

At the heart of KODE Labs’ innovation lies its enterprise platform, a sophisticated solution that integrates data from diverse building management systems, IoT devices, and operational systems into a unified, cloud-based infrastructure. This seamless integration enables KODE Labs to standardize and organize data at scale, positioning the company as a trailblazer in AI technology tailored for buildings.

With a proven track record of reducing energy consumption and carbon emissions by up to 30%, KODE Labs’ platform has garnered acclaim from Fortune 500 corporations, retailers, financial institutions, and global REITs across various sectors. By prioritizing user experience and operational excellence, KODE Labs has established itself as a leader in sustainable real estate management.

The Series B funding will fuel KODE Labs’ expansion and AI development efforts, enabling the company to further innovate building operations and experiences. By analyzing vast amounts of data, KODE Labs aims to create buildings that prioritize human experience and environmental impact, envisioning a future where efficiency meets human-centric design.

Since its inception, KODE Labs has forged partnerships with renowned companies such as QuadReal, Bedrock Detroit, Stream Realty, Hines, Ford, and other global corporations and REITs. With this latest investment, KODE Labs is poised to accelerate its expansion across North America, Europe, and Australia, solidifying its position as a driving force in the transition towards sustainable real estate management.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Streamlining Video Podcast Production: The Rise of PodcastVideos.com

Podcasting has rapidly grown in popularity in the past few years. Every day we see new podcast ideas popping up, from celebrity talk shows to fitness advice to true crime. PodcastVideos.com is working to meet the needs of these creators, deleting friction from the production and distribution of video podcasts.

Founded by entrepreneur Eric Howerton, the company is reshaping the podcasting landscape by offering professional-level studios and turnkey services tailored to creators of all levels, from aspiring podcasters to Fortune 500 companies.

With PodcastVideos.com, anyone with a podcast idea can book recording time at one of their state-of-the-art studios, starting at an accessible price point. For a comprehensive package including audio and video recording, editing, custom intros, and social media teasers, creators can opt for a membership plan, ensuring a seamless experience from start to finish.

What sets PodcastVideos.com apart is its commitment to quality and convenience. The company boasts five studios with different configurations, equipped with pre-lit setups and screens for presentations or branding. Moreover, their efficient workflow ensures a swift turnaround time, with the goal of delivering the final product within 48 hours of production.

Beyond production, PodcastVideos.com offers support in distribution and promotion, helping creators reach their audience across various platforms such as Apple, Google, YouTube, and more. By providing guidance on search engine optimization and marketing strategies, the company empowers creators to maximize their reach and potentially secure sponsorships.

While PodcastVideos.com caters primarily to businesses and professionals, its versatility extends to personal projects as well. From corporate podcasts to family vacation recaps, the studio serves as a creative hub where ideas come to life. This inclusive approach reflects Howerton’s entrepreneurial spirit, honed through years of experience with ventures like “Get Out” magazine and the creative agency WhyteSpyder.

As PodcastVideos.com continues to expand its footprint, with plans to scale into larger metro markets, it represents a beacon of innovation in the podcasting realm. With a bootstrapped foundation and a vision for growth, Howerton’s venture is poised to redefine the way video podcasts are created, shared, and experienced in the digital age.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Nectero Medical Secures Funds in Fight Against Advancing Abdominal Aortic Aneurysm

Nectero Medical Inc., a pioneering medical technology company based in Tempe, Arizona, has reached a significant milestone in its mission to revolutionize the treatment of abdominal aortic aneurysm (AAA). With the successful closure of a $96 million Series D financing round, Nectero is poised to accelerate the development of its innovative abdominal aortic aneurysm treatment.

Led by Norwest Venture Partners, the Series D round saw substantial contributions from renowned firms such as Boston Scientific, BioStar Capital, Cadence Healthcare Ventures, and Aphelion Capital. This substantial investment will propel Nectero’s Phase II/III stAAAble trial forward and support the submission of an FDA new drug application for its groundbreaking Nectero EAST system.

The Nectero EAST system represents a new approach to AAA treatment, offering a minimally invasive solution with the potential to transform patient outcomes. Designed as an endovascular aneurysm stabilization treatment, EAST features a dual-balloon delivery catheter and a proprietary stabilizer mixture containing pentagalloyl glucose (PGG). This innovative approach strengthens the aortic vessel wall by delivering PGG locally into the aneurysmal wall, reducing the risk of further degradation and rupture.

One of the key advantages of the EAST system is its simplicity and efficiency. The procedure requires no specialized tools and can be completed in less than an hour, offering a streamlined alternative to traditional open surgery. Moreover, EAST leaves behind no permanent implant and does not preclude future interventions, providing patients with a versatile and effective treatment option.

With FDA fast track designation granted last August, Nectero is well-positioned to accelerate the development and regulatory approval of its groundbreaking technology. The addition of Dr. Zack Scott and Dr. Alan Davis to the Nectero board of directors further strengthens the company’s leadership team, bringing invaluable expertise and insight to guide its future growth and success.

AAA poses a significant health risk, affecting approximately 1.4% of individuals aged 50 to 84 in the United States. With aging, tobacco use, and certain medical conditions contributing to the weakening of the aorta’s wall, the need for innovative treatment options is more pressing than ever. Nectero’s commitment to advancing AAA treatment represents a beacon of hope for patients and healthcare providers alike, offering the promise of improved outcomes and enhanced quality of life.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Manifold Bio Secues $15M in Series A Funding

Massachusetts-based startup, Manifold Bio, has secured $15 million in funding to continue research into leveraging artificial intelligence to revolutionize cancer studies. The Series A funding round was led by TQ Ventures and saw participation from new investors including Calibrate Ventures and SK Ventures.

With a mission to modernize the tech infrastructure of clinical research organizations, Manifold Bio has developed an AI-based platform that streamlines manual workflows and reduces administrative burdens for cancer centers. This platform, known as the mDesign™ Platform, accelerates the time to insights from months to minutes, marking a significant advancement in cancer research.

Vinay Seth Mohta, CEO and co-founder of Manifold Bio, highlights the critical need for such innovation in healthcare. By moving away from legacy technologies like Excel spreadsheets, Manifold Bio aims to provide researchers with a purpose-built tech infrastructure that enhances efficiency and productivity.

Supported by this latest funding round, Manifold Bio is poised to expand its partnerships with healthcare organizations and invest in research and development to further enhance its platform’s capabilities. Early adopters, including Indiana University Melvin and Bren Simon Comprehensive Cancer Center and Winship Cancer Institute of Emory University, have already witnessed the transformative impact of Manifold Bio’s technology.

One of the key features of Manifold Bio’s platform is its ability to unify vast amounts of healthcare data into a single platform, facilitating seamless collaboration and data analysis. This not only accelerates research studies but also reduces costs and manual efforts associated with traditional research workflows.

Anna Maria Storniolo, M.D., medical director at IU Melvin and Bren Simon Comprehensive Cancer Center, praises Manifold Bio’s platform as a game-changer in cancer research. With the ability to respond to research requests in minutes rather than weeks, researchers can now conduct studies with unprecedented speed and efficiency.

Looking ahead, Manifold Bio remains committed to pushing the boundaries of AI technology in healthcare. With a focus on advancing data curation and analysis, Manifold Bio aims to empower researchers with even more advanced tools and capabilities in the near future.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

Schedule a Teleconference

directive for LBI taxpayers

Upcoming Webinars

Register Here

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

Register Here

water tech

Upcoming Webinars

Register Here

Choose your state

find-us-map

Solstar Space Co.’s Innovations Propel Communication in Low Earth Orbit

Solstar Space Co., based in Santa Fe, New Mexico, is making strides in space technology with its recent $1.25 million Small Business Innovation Phase II research contract from AFWERX, the U.S. Air Force’s innovation arm. This contract aims to tackle critical challenges faced by the Department of Defense, particularly in the realm of space communications.

At the forefront of Solstar’s development efforts is the Continuous Spacecraft System Communications Wideband (CSSC-WB) unit, also known as the Slayton Space Communicator. Designed to revolutionize communication in Low Earth Orbit (LEO), the Slayton Space Communicator offers high-speed downlink and uplink capabilities, enhancing connectivity with spacecraft and personnel operating in this vital region of space.

The significance of Solstar’s innovation lies in its ability to minimize communication blackout periods caused by limited ground station links. With the Slayton Space Communicator, Solstar aims to provide near real-time access to large data files, including remote sensing images and video streams. Brian Barnett, CEO of Solstar Space, emphasizes the importance of such capabilities as LEO becomes increasingly congested, highlighting the need for complete situational awareness for organizations like the U.S. Space Force.

In light of recent incidents involving space debris, such as the unexpected crash of a piece of hardware from the International Space Station, the importance of effective communication and monitoring in space has become more apparent than ever. Solstar’s innovative solutions not only enhance connectivity but also contribute to improving safety and efficiency in space operations.

As Solstar Space continues its research and development efforts with the support of AFWERX and other partners, the future of space communication looks promising. With its commitment to pushing the boundaries of technology, Solstar is poised to play a significant role in shaping the future of space exploration and satellite communication.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Revolutionizing Building Insulation: CleanFiber’s $28M Series B Funding Round

CleanFiber Inc., a Buffalo-based materials science startup, is making waves in the construction industry with its innovative approach to building insulation. Recently, the company secured a remarkable $28 million Series B equity funding round, marking a significant milestone in its journey towards sustainable growth.

Founded on the principles of environmental stewardship and technological innovation, CleanFiber manufactures building insulation from recycled corrugated cardboard. This unique approach not only addresses the pressing need for sustainable construction materials but also offers a practical solution to waste management challenges.

Led by CEO Jonathan Strimling, CleanFiber has rapidly gained traction in the market, attracting investments from prominent sustainability-focused firms such as Spring Lane Capital, Climate Innovation Capital, AXA IM Alts, and Tokyu Construction/Global Brain. With the recent Series B round, CleanFiber’s total capital raised, including both equity and debt, has soared to over $100 million.

The company’s success story is deeply rooted in its commitment to innovation and community engagement. After winning a $500,000 prize in the 43North contest, CleanFiber relocated to Buffalo seven years ago, establishing its presence in the region’s burgeoning startup ecosystem. Over the years, the company has expanded its operations, employing approximately 95 people and transforming its factory on the former Bethlehem Steel site in Blasdell into a hub of sustainable manufacturing.

CleanFiber’s impressive growth trajectory is reflected in its year-over-year revenue, which has surged by at least 140% over the last three years. The Series B funding will further accelerate this growth by enabling the company to scale production, diversify its product portfolio, and enhance its market reach through strategic sales and marketing initiatives.

As one of the largest local raises in 2023, CleanFiber’s Series B funding underscores the growing investor interest in sustainable technologies and the company’s potential to drive positive change in the construction industry. With a clear vision and robust financial backing, CleanFiber is poised to revolutionize building insulation and set new standards for eco-friendly construction practices.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Xevant: Pioneering Data Analytics for a More Efficient Pharmacy Benefit Landscape

Xevant, Inc, a company dedicated to revolutionizing the pharmacy benefit landscape, recently announced their commitment to accelerated growth with a significant follow-on investment. This financial backing underscores the growing recognition of their innovative data analytics platform designed to help pharmacy benefit organizations (PBMs) navigate the complexities of the healthcare system.

PBMs play a crucial role in managing prescription drug costs for various stakeholders, including employers, health plans, and individual consumers. However, navigating the intricate world of pharmacy benefits can be challenging due to complex data analysis and reporting requirements.

Xevant addresses this challenge by providing automated data analytics and reporting tools specifically tailored for PBMs. This innovative platform empowers PBMs with the ability to:

Gain deeper insights: Xevant’s technology analyzes vast amounts of data related to drug utilization, pricing, and trends, providing PBMs with a comprehensive understanding of their clients’ needs and opportunities for cost savings.
Make informed decisions: Armed with these insights, PBMs can make data-driven decisions regarding drug formularies, network contracting, and other vital aspects of their operations.
Improve efficiency: Xevant’s platform automates various tasks, streamlining workflows and freeing up valuable time for PBM teams to focus on strategic initiatives.

By leveraging Xevant’s cutting-edge technology, PBMs can not only reduce costs but also enhance the overall quality of care for their clients. This translates to improved health outcomes, increased affordability, and a more efficient healthcare system for everyone involved.

Xevant’s commitment to innovation extends beyond their initial product offering. They continuously invest in research and development to further enhance their platform and stay at the forefront of the ever-evolving healthcare landscape. This dedication to progress ensures that PBMs can rely on Xevant to provide them with the tools they need to navigate the complexities of the pharmaceutical industry and deliver optimal results for their clients.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Sage Geosystems Secures $17 Million to Build Commercial Geopressured Geothermal System

Sage Geosystems, a Houston-based company at the forefront of geothermal innovation, recently secured a significant $17 million Series A funding round. This investment serves as a major boost for their ambitious project: constructing the world’s first commercial geopressured geothermal (GGS) facility in Texas.

Geothermal energy, which utilizes the Earth’s internal heat to generate electricity, holds immense potential as a clean and sustainable energy source. However, traditional geothermal systems rely on accessing hot rock formations deep underground, which can be geographically limited and require complex drilling techniques.

Sage Geosystems takes a novel approach by tapping into geopressured reservoirs. These naturally occurring underground formations contain hot brine under immense pressure. This unique combination of heat and pressure allows Sage Geosystems to generate electricity without the need for deep drilling, making their technology more scalable and adaptable compared to traditional methods.

The $17 million funding will be directed towards the construction of a three-megawatt (MW) GGS facility in Texas. This pilot project represents a significant step forward in proving the commercial viability of geopressured geothermal technology.

The potential benefits of Sage Geosystems’ innovation are multifaceted:

Clean and Sustainable Energy: GGS technology offers a reliable and baseload renewable energy source, contributing to the reduction of greenhouse gas emissions and dependence on fossil fuels.
Scalability and Adaptability: Unlike traditional geothermal methods, GGS systems can potentially be deployed in various locations with geopressured resources, making them a more widely applicable solution.
Economic Benefits: The development of this technology has the potential to create new jobs and stimulate economic growth in the regions where it is implemented.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Osazda Energy Soars with SBIR Grant for Self-Healing Solar Cell Technology

Osazda Energy, a company dedicated to pushing the boundaries of solar energy, has received a significant boost with a recent Small Business Innovation Research (SBIR) grant. This prestigious award recognizes their groundbreaking research and development (R&D) efforts in creating a revolutionary self-healing solar cell technology with the potential to transform the energy landscape.

While Osazda’s technology boasts increased efficiency, its true innovation lies in its ability to combat a major challenge plaguing the industry: cell cracking. As solar panels become thinner and lighter for various applications, they become more susceptible to developing cracks, leading to performance degradation and electrical losses.

This is where Osazda’s MetZilla Paste and MetZilla Plate technologies come in. These innovative solutions, incorporating nanomaterials into the metallization process, allow cracked cells to self-heal and regain electrical continuity. This translates to several key benefits:

Extended lifespan: By addressing the issue of cell cracking, a major contributor to solar panel degradation, Osazda’s technology has the potential to double the lifespan of solar panels, reaching 40-50 years compared to the current industry standard of 25 years. This translates to significant cost savings in the long run.
Reduced Levelized Cost of Electricity (LCOE): Increased panel lifespan directly impacts the LCOE, making solar energy more affordable and accessible for a wider range of users.
Weight reduction: Thinner panels are crucial for drones and spacecraft due to weight limitations. Osazda’s technology enables the use of thinner panels without compromising durability, enhancing the capabilities of these vehicles.

The SBIR grant serves as a significant validation of Osazda’s innovative approach. It provides essential funding to further develop and commercialize their self-healing technology, paving the way for a more sustainable and cost-effective future for solar energy across terrestrial, UAV, and space applications. Osazda Energy is not just pushing the boundaries of efficiency; they are revolutionizing the way we think about solar power altogether.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.